Developing and Testing an Online Pathway From Screening to Treatment for Depression in Oncology: iPath*D (Aim 2)

Launched by DARTMOUTH-HITCHCOCK MEDICAL CENTER · Mar 21, 2022

Keywords

ClinConnect Summary

This clinical trial, called iPath*D, is exploring an online program designed to help patients receiving cancer treatment who are experiencing depression. The goal is to see if this online pathway is easy to use and acceptable for patients who report feeling depressed. If you're a new patient starting treatment at Dartmouth Cancer Center North and have symptoms of depression, you might be eligible to participate. Specifically, you must be at least 18 years old, comfortable communicating in English, and have a certain level of depression based on a health questionnaire.

If you decide to join the trial, you'll be asked to try out this online pathway and share your experiences. However, not everyone can participate. For instance, people with mild depression, those who have had serious thoughts of self-harm, or those currently receiving mental health treatment are excluded. The trial is currently recruiting, and your feedback could help improve support for patients dealing with both cancer and depression.

Gender

ALL

Eligibility criteria

• • Inclusion criteria
• • 1. Adults (≥18 years)
• • 2. New patients who are beginning treatment at Dartmouth Cancer Center North and returning for their chemo teach or radiation simulation visit
• • 3. Can communicate in English
• • 4. PHQ-9 ≥10 and ≤27
• • Exclusion criteria
• • 1. Mild Depression (PHQ-9 ≥10)
• • 2. Individuals who screen positive for suicidal ideation with method, intent, plan or a recent prior suicide/self-harm attempt, as determined by a positive endorsement of items 3, 4, 5 or 6 on the Columbia-Suicide Severity Rating Scale (C-SSR).
• • 3. Individuals with bipolar disorder or psychosis (documented in the EMR)
• • 4. Individuals currently receiving treatment for a mental health condition (documented in the EMR or self-reported during eligibility screening)
• • 5. Significant cognitive impairment (Callahan's Six Item Screener of cognitive function ≤ 4; Self-reported during eligibility screening)